Showing results (31-40 of 39) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 39 results.
Cancer Research|August 21, 2020
A DNA Hypomethylating Drug Alters the Tumor Microenvironment and Improves the Effectiveness of Immune Checkpoint Inhibitors in a Mouse Model of Pancreatic CancerTamas A Gonda, Jarwei Fang, Martha Salas, et al.
Breast Cancer Research and Treatment|September 20, 2024
Genomic and transcriptomic landscape of HER2-low breast cancerRani Bansal, Tolulope Adeyelu, Andrew Elliott, et al.
Future Oncology (London, England)|January 9, 2023
Many People With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma Benefit From Ibrutinib Treatment Up To 8 Years: A Plain Language SummaryPaul M Barr, Carolyn Owen, Tadeusz Robak, et al.
Blood Advances|April 4, 2022
Up to 8-year follow-up from RESONATE-2: first-line ibrutinib treatment for patients with chronic lymphocytic leukemiaPaul M Barr, Carolyn Owen, Tadeusz Robak, et al.
The Lancet. Oncology|December 8, 2018
Ibrutinib plus obinutuzumab versus chlorambucil plus obinutuzumab in first-line treatment of chronic lymphocytic leukaemia (iLLUMINATE): a multicentre, randomised, open-label, phase 3 trialCarol Moreno, Richard Greil, Fatih Demirkan, et al.
Science (New York, N.Y.)|July 23, 2026
Epigenetic and 3D genome reprogramming during the aging of the human hippocampusNathan R Zemke, Seoyeon Lee, Sainath Mamde, et al.
Clinical Lymphoma, Myeloma & Leukemia|September 26, 2018
Improvement in Parameters of Hematologic and Immunologic Function and Patient Well-being in the Phase III RESONATE Study of Ibrutinib Versus Ofatumumab in Patients With Previously Treated Chronic Lymphocytic Leukemia/Small Lymphocytic LymphomaJacqueline C Barrientos, Susan O'Brien, Jennifer R Brown, et al.
JAMA Oncology|November 3, 2022
Interplay of Immunosuppression and Immunotherapy Among Patients With Cancer and COVID-19Ziad Bakouny, Chris Labaki, Punita Grover, et al.
Lancet (London, England)|June 1, 2020
Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort studyNicole M Kuderer, Toni K Choueiri, Dimpy P Shah, et al.
Pageof 4